…breast cancer (TBNC). 108600 targets and inhibits breast cancer stem cells, a subpopulation of cells found within patient triple negative breast cancers that can promote resistance to chemotherapy, making it…

Moderna has dosed the first patients in the Phase I study of mRNA-6231, the company’s mRNA-encoded IL-2, modified for the expansion of regulatory T cells. mRNA-6231 is Moderna’s first autoimmune…

…therapy that uses modified T-cells to treat certain cancers. With the possibility of using the body to target cancer cells, while avoiding damage to surrounding tissue, the application of CGT…

…how the SARS-CoV-2 spike protein interacts with mammalian lung cell membranes, allowing the viral RNA to enter human cells. Helping Indian biotherapeutic companies advance novel therapeutics Fusion Antibodies and BioTickle,…

…organised in three dimensions, rather than the conventional two-dimensional arrangement of individual cells in a petri dish. Professor Beggs said: “Organoids are essentially miniature organs. The cells are grouped together…

…seed, grow and differentiate cells prior to performing more conventional assays in well plates. Cells grow on, around and into the material, forming a micro-island of adherent cells that are…

…technology that takes the pieces of biological machinery required for protein production and combines them into an extract that can be used to create enzymes synthetically, without requiring living cells…

…on-site immune cell isolations, point-of-care testing services, and cryopreservation capabilities. Leukopaks, which contain concentrated white blood cells, are used to help identify promising new drug candidates, assess toxicity levels, and…

…published new data on how the SARS-CoV-2 spike protein interacts with mammalian lung cell membranes, allowing the viral RNA to enter human cells. The purpose of the SARS-CoV-2 spike protein…

…enhanced tumour cell cytotoxicity as well as selectivity over immune cells in the same microenvironment. Dr Mingxi Li, President of GT Apeiron Therapeutics, said: “We have been incredibly impressed by…